These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
537 related articles for article (PubMed ID: 33741405)
101. Potency trends of Δ9-tetrahydrocannabinol, cannabidiol and cannabinol in cannabis in the Netherlands: 2005-15. Niesink RJ; Rigter S; Koeter MW; Brunt TM Addiction; 2015 Dec; 110(12):1941-50. PubMed ID: 26234170 [TBL] [Abstract][Full Text] [Related]
102. Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transition in vitro. Milian L; Mata M; Alcacer J; Oliver M; Sancho-Tello M; Martín de Llano JJ; Camps C; Galbis J; Carretero J; Carda C PLoS One; 2020; 15(2):e0228909. PubMed ID: 32049991 [TBL] [Abstract][Full Text] [Related]
103. Fatty acid-binding proteins (FABPs) are intracellular carriers for Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD). Elmes MW; Kaczocha M; Berger WT; Leung K; Ralph BP; Wang L; Sweeney JM; Miyauchi JT; Tsirka SE; Ojima I; Deutsch DG J Biol Chem; 2015 Apr; 290(14):8711-21. PubMed ID: 25666611 [TBL] [Abstract][Full Text] [Related]
104. Plant-Based Cannabinoids for the Treatment of Chronic Neuropathic Pain. Casey SL; Vaughan CW Medicines (Basel); 2018 Jul; 5(3):. PubMed ID: 29966400 [TBL] [Abstract][Full Text] [Related]
105. Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing. Fusar-Poli P; Crippa JA; Bhattacharyya S; Borgwardt SJ; Allen P; Martin-Santos R; Seal M; Surguladze SA; O'Carrol C; Atakan Z; Zuardi AW; McGuire PK Arch Gen Psychiatry; 2009 Jan; 66(1):95-105. PubMed ID: 19124693 [TBL] [Abstract][Full Text] [Related]
106. Cannabidiol attenuates the appetitive effects of Delta 9-tetrahydrocannabinol in humans smoking their chosen cannabis. Morgan CJ; Freeman TP; Schafer GL; Curran HV Neuropsychopharmacology; 2010 Aug; 35(9):1879-85. PubMed ID: 20428110 [TBL] [Abstract][Full Text] [Related]
107. Effect of low doses of delta9-tetrahydrocannabinol and cannabidiol on the extinction of cocaine-induced and amphetamine-induced conditioned place preference learning in rats. Parker LA; Burton P; Sorge RE; Yakiwchuk C; Mechoulam R Psychopharmacology (Berl); 2004 Sep; 175(3):360-6. PubMed ID: 15138755 [TBL] [Abstract][Full Text] [Related]
108. A Multicriteria Decision Analysis Comparing Pharmacotherapy for Chronic Neuropathic Pain, Including Cannabinoids and Cannabis-Based Medical Products. Nutt DJ; Phillips LD; Barnes MP; Brander B; Curran HV; Fayaz A; Finn DP; Horsted T; Moltke J; Sakal C; Sharon H; O'Sullivan SE; Williams T; Zorn G; Schlag AK Cannabis Cannabinoid Res; 2022 Aug; 7(4):482-500. PubMed ID: 33998895 [No Abstract] [Full Text] [Related]
109. Effect of sublingual application of cannabinoids on intraocular pressure: a pilot study. Tomida I; Azuara-Blanco A; House H; Flint M; Pertwee RG; Robson PJ J Glaucoma; 2006 Oct; 15(5):349-53. PubMed ID: 16988594 [TBL] [Abstract][Full Text] [Related]
110. The Effect of Orally Administered Δ9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD) on Obesity Parameters in Mice. Eitan A; Gover O; Sulimani L; Meiri D; Schwartz B Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762099 [TBL] [Abstract][Full Text] [Related]
111. Effects of cannabidiol and Δ Smith SA; Le GH; Teopiz KM; Kwan ATH; Rhee TG; Ho RC; Wu J; Cao B; Ceban F; McIntyre RS Drug Metab Rev; 2024; 56(2):164-174. PubMed ID: 38655747 [TBL] [Abstract][Full Text] [Related]
112. Potency of Δ Potter DJ; Hammond K; Tuffnell S; Walker C; Di Forti M Drug Test Anal; 2018 Apr; 10(4):628-635. PubMed ID: 29441730 [TBL] [Abstract][Full Text] [Related]
113. Antinociceptive effects of minor cannabinoids, terpenes and flavonoids in Cannabis. Rodriguez CEB; Ouyang L; Kandasamy R Behav Pharmacol; 2022 Apr; 33(2&3):130-157. PubMed ID: 33709984 [TBL] [Abstract][Full Text] [Related]
114. Short-Term Cannabidiol with Δ-9-Tetrahydrocannabinol in Parkinson's Disease: A Randomized Trial. Liu Y; Bainbridge J; Sillau S; Rajkovic S; Adkins M; Domen CH; Thompson JA; Seawalt T; Klawitter J; Sempio C; Chin G; Forman L; Fullard M; Hawkins T; Seeberger L; Newman H; Vu D; Leehey MA Mov Disord; 2024 May; 39(5):863-875. PubMed ID: 38487964 [TBL] [Abstract][Full Text] [Related]
115. Effects of cannabidiol and Δ9-tetrahydrocannabinol in the elevated plus maze in mice. Liu J; Scott BW; Burnham WM Behav Pharmacol; 2022 Apr; 33(2&3):206-212. PubMed ID: 33883447 [TBL] [Abstract][Full Text] [Related]
116. Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedside. Rahn EJ; Hohmann AG Neurotherapeutics; 2009 Oct; 6(4):713-37. PubMed ID: 19789075 [TBL] [Abstract][Full Text] [Related]
117. Cannabidiol in the prelimbic cortex modulates the comorbid condition between the chronic neuropathic pain and depression-like behaviour in rats: The role of medial prefrontal cortex 5-HT Malvestio RB; Medeiros P; Negrini-Ferrari SE; Oliveira-Silva M; Medeiros AC; Padovan CM; Luongo L; Maione S; Coimbra NC; de Freitas RL Brain Res Bull; 2021 Sep; 174():323-338. PubMed ID: 34192579 [TBL] [Abstract][Full Text] [Related]
118. The effect of delta-9-tetrahydrocannabinol and cannabidiol on p50 of the oxygen haemoglobin dissociation curve. James TR; Watson CT; Pepple DJ Fitoterapia; 2020 Jun; 143():104539. PubMed ID: 32147492 [TBL] [Abstract][Full Text] [Related]
119. Combination of cannabinoids, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), mitigates experimental autoimmune encephalomyelitis (EAE) by altering the gut microbiome. Al-Ghezi ZZ; Busbee PB; Alghetaa H; Nagarkatti PS; Nagarkatti M Brain Behav Immun; 2019 Nov; 82():25-35. PubMed ID: 31356922 [TBL] [Abstract][Full Text] [Related]
120. The anti-inflammatory effects of cannabidiol and cannabigerol alone, and in combination. Robaina Cabrera CL; Keir-Rudman S; Horniman N; Clarkson N; Page C Pulm Pharmacol Ther; 2021 Aug; 69():102047. PubMed ID: 34082108 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]